Universal Inpatient Screening for Methicillin Resistant Staphylococcus Aureus (MRSA) Substantially Reduces Noscomial MRSA Infection Rates: May 2007 to May 2012

Universal Inpatient Screening for Methicillin Resistant Staphylococcus Aureus (MRSA) Substantially Reduces Noscomial MRSA Infection Rates: May 2007 to May 2012

Methicillin Resistant Staphylococcus aureas (MRSA) has repeatedly been shown to increase length of stay, morbidity and mortality. Excess costs associated with MRSA infections are estimated to be $28,000 to $35,000. In December of 2007 we instituted a program of universal MRSA screening of all patien...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of infection control 2013-06, Vol.41 (6), p.S112-S112
Hauptverfasser: Parada, Jorge P., MD, MPH, Durazo, Ramon, PhD, Kamath, Deepa, DO, MPH, Tomich, Alexander, RN, MSN, DNP, Marinakos-Trulis, Gigi, Challapalli, Malliswari, MD, Schreckenberger, Paul, PhD
Format: Artikel
Sprache:eng
Schlagworte:
Drug resistance
Infection Control
Infectious Disease
Inpatient care
Medical screening
Nosocomial infections
Staphylococcus infections
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Methicillin Resistant Staphylococcus aureas (MRSA) has repeatedly been shown to increase length of stay, morbidity and mortality. Excess costs associated with MRSA infections are estimated to be $28,000 to $35,000. In December of 2007 we instituted a program of universal MRSA screening of all patients admitted to our 561 bed tertiary care medical center with 167 designated Intensive Care Unit (ICU) beds using the Cepheid GeneXpert rapid PCR active surveillance for MRSA.
ISSN:0196-6553
1527-3296
DOI:10.1016/j.ajic.2013.03.227